<VariationArchive VariationID="521393" VariationName="NM_000074.3(CD40LG):c.559del (p.Ala187fs)" VariationType="Deletion" Accession="VCV000521393" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-04-06" DateCreated="2018-04-15" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="512593" VariationID="521393">
      <GeneList>
        <Gene Symbol="CD40LG" FullName="CD40 ligand" GeneID="959" HGNC_ID="HGNC:11935" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq26.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="136648158" stop="136660390" display_start="136648158" display_stop="136660390" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="135730335" stop="135742548" display_start="135730335" display_stop="135742548" Strand="+" />
          </Location>
          <OMIM>300386</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CD40LG">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CD40LG">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000074.3(CD40LG):c.559del (p.Ala187fs)</Name>
      <CanonicalSPDI>NC_000023.11:136659187:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq26.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="136659188" stop="136659188" display_start="136659188" display_stop="136659188" variantLength="1" positionVCF="136659187" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="135741347" stop="135741347" display_start="135741347" display_stop="135741347" variantLength="1" positionVCF="135741346" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>A187fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000074.2" sequenceAccession="NM_000074" sequenceVersion="2" change="c.559delG">
            <Expression>NM_000074.2:c.559delG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_141" sequenceAccession="LRG_141">
            <Expression>LRG_141:g.16012del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.135741347del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.135741347del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.136659188del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.136659188del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007280.1" sequenceAccession="NG_007280" sequenceVersion="1" change="g.16012del">
            <Expression>NG_007280.1:g.16012del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000074.3" sequenceAccession="NM_000074" sequenceVersion="3" change="c.559del" MANESelect="true">
            <Expression>NM_000074.3:c.559del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000065.1" sequenceAccession="NP_000065" sequenceVersion="1" change="p.Ala187fs">
            <Expression>NP_000065.1:p.Ala187fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658799877" DB="ClinGen" />
        <XRef Type="rs" ID="1556143529" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000074.3(CD40LG):c.559del (p.Ala187fs) AND Inborn genetic diseases" Accession="RCV000622392" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-05-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000074.3(CD40LG):c.559del (p.Ala187fs) AND Hyper-IgM syndrome type 1" Accession="RCV003512068" Version="1">
        <ClassifiedConditionList TraitSetID="3084">
          <ClassifiedCondition DB="MedGen" ID="C0398689">Hyper-IgM syndrome type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-11" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-04-15" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10366125</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15358621</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35753512</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8094231</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3084" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5326" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hyper-IgM syndrome type 1</ElementValue>
                <XRef ID="MONDO:0010626" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyper IgM immunodeficiency, X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyper-IgM Immunodeficiency Syndrome, Type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked hyper-IgM syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency with hyper IgM type 1</ElementValue>
                <XRef ID="Immunodeficiency+with+hyper+IgM+type+1/3776" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">XHIM</ElementValue>
                <XRef Type="MIM" ID="308230" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HIGM</ElementValue>
                <XRef Type="MIM" ID="308230" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IHIS</ElementValue>
                <XRef Type="MIM" ID="308230" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HIGM1</ElementValue>
                <XRef Type="MIM" ID="308230" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">X-linked hyper IgM syndrome (HIGM1), a disorder of abnormal T- and B-cell function, is characterized by low serum concentrations of IgG, IgA, and IgE with normal or elevated serum concentrations of IgM. Mitogen proliferation may be normal, but NK- and T-cell cytotoxicity can be impaired. Antigen-specific responses are usually decreased or absent. Total numbers of B cells are normal but there is a marked reduction of class-switched memory B cells. Defective oxidative burst of both neutrophils and macrophages has been reported. The range of clinical findings varies, even within the same family. More than 50% of males with HIGM1 develop symptoms by age one year, and more than 90% are symptomatic by age four years. HIGM1 usually presents in infancy with recurrent upper- and lower-respiratory tract bacterial infections, opportunistic infections including Pneumocystis jirovecii pneumonia, and recurrent or protracted diarrhea that can be infectious or noninfectious and is associated with failure to thrive. Neutropenia is common; thrombocytopenia and anemia are less commonly seen. Autoimmune and/or inflammatory disorders (such as sclerosing cholangitis) as well as increased risk for neoplasms have been reported as medical complications of this disorder. Significant neurologic complications, often the result of a CNS infection, are seen in 5%-15% of affected males. Liver disease, a serious complication of HIGM1 once observed in more than 80% of affected males by age 20 years, may be decreasing with adequate screening and treatment of Cryptosporidium infection.</Attribute>
                <XRef ID="NBK1402" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="73" />
                <XRef ID="73" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301576</ID>
                <ID Source="BookShelf">NBK1402</ID>
              </Citation>
              <XRef ID="101088" DB="Orphanet" />
              <XRef ID="C0398689" DB="MedGen" />
              <XRef ID="MONDO:0010626" DB="MONDO" />
              <XRef Type="MIM" ID="308230" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1445759" SubmissionDate="2020-10-09" DateLastUpdated="2023-01-07" DateCreated="2018-04-15">
        <ClinVarSubmissionID localKey="a6273494" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000741965" DateUpdated="2023-01-07" DateCreated="2018-04-15" Type="SCV" Version="3" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-05-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15358621</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8094231</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry exome assertion method (8-5-2015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/xlwdlsvu/ambry_exome_assertion_method_8-5-2015_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Asian/Hispanic</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
              <FamilyData PedigreeID="a919773" />
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Seizures</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Headache</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002315" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Immunodeficiency</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002721" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Increased antibody level in blood</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0010702" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Developmental regression</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002376" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Personality changes</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000751" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Memory impairment</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002354" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Inappropriate laughter</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000748" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Emotional lability</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000712" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Cerebral atrophy</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002059" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of brain morphology</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0012443" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">EEG abnormality</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002353" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CD40LG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000074.2:c.559delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MeSH" ID="D030342" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>NovelandUpdateExomeDeposit_ExomeProgenyThrough080120</SubmissionName>
          <SubmissionName>exome clinvar deposit 2.18.18</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7984624" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4979604|MedGen:C0398689" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004299000" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15358621</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35753512</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10366125</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala187Leufs*4) in the CD40LG gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 75 amino acid(s) of the CD40LG protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of X-linked hyper-IgM syndrome (PMID: 15358621, 35753512). This variant is also known as 580DelG . ClinVar contains an entry for this variant (Variation ID: 521393). This variant disrupts a region of the CD40LG protein in which other variant(s) (p.Gly257Asp) have been determined to be pathogenic (PMID: 10366125; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CD40LG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.135741347del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0398689" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1445759" TraitType="Finding" MappingType="Name" MappingValue="Increased antibody level in blood" MappingRef="Preferred">
        <MedGen CUI="C5397581" Name="Increased circulating antibody level" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445759" TraitType="Finding" MappingType="Name" MappingValue="Seizures" MappingRef="Preferred">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445759" TraitType="Finding" MappingType="Name" MappingValue="EEG abnormality" MappingRef="Preferred">
        <MedGen CUI="C0151611" Name="EEG abnormality" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445759" TraitType="Finding" MappingType="Name" MappingValue="Cerebral atrophy" MappingRef="Preferred">
        <MedGen CUI="C0235946" Name="Cerebral atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445759" TraitType="Finding" MappingType="Name" MappingValue="Immunodeficiency" MappingRef="Preferred">
        <MedGen CUI="C0021051" Name="Immunodeficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445759" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of brain morphology" MappingRef="Preferred">
        <MedGen CUI="C4021085" Name="Abnormal brain morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445759" TraitType="Finding" MappingType="Name" MappingValue="Memory impairment" MappingRef="Preferred">
        <MedGen CUI="C0233794" Name="Memory impairment" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7984624" TraitType="Disease" MappingType="XRef" MappingValue="C0398689" MappingRef="MedGen">
        <MedGen CUI="C0398689" Name="Hyper-IgM syndrome type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445759" TraitType="Finding" MappingType="Name" MappingValue="Emotional lability" MappingRef="Preferred">
        <MedGen CUI="C0085633" Name="Emotional lability" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445759" TraitType="Disease" MappingType="XRef" MappingValue="D030342" MappingRef="MeSH">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445759" TraitType="Finding" MappingType="Name" MappingValue="Headache" MappingRef="Preferred">
        <MedGen CUI="C0018681" Name="Headache" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445759" TraitType="Finding" MappingType="Name" MappingValue="Developmental regression" MappingRef="Preferred">
        <MedGen CUI="C1836830" Name="Developmental regression" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445759" TraitType="Finding" MappingType="Name" MappingValue="Inappropriate laughter" MappingRef="Preferred">
        <MedGen CUI="C0424304" Name="Inappropriate laughter" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445759" TraitType="Finding" MappingType="Name" MappingValue="Personality changes" MappingRef="Preferred">
        <MedGen CUI="C0240735" Name="Personality changes" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

